ReviewFrontiers in pharmacology2025

Targeting the P2X7 receptor in cerebrovascular diseases: from molecular mechanisms to preclinical therapeutic potential.

Ziyan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.